<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, some respiratory viruses (e.g., 
 <italic>Rhinoviruses</italic>) frequently appear to be the only or the most abundant pathogens in samples from patients with respiratory infections [
 <xref rid="B64-viruses-12-00211" ref-type="bibr">64</xref>]. This pattern implies that either the diagnostic tools are erroneous [
 <xref rid="B65-viruses-12-00211" ref-type="bibr">65</xref>,
 <xref rid="B66-viruses-12-00211" ref-type="bibr">66</xref>,
 <xref rid="B67-viruses-12-00211" ref-type="bibr">67</xref>,
 <xref rid="B68-viruses-12-00211" ref-type="bibr">68</xref>] or the groups of related viruses cause infections with a variable clinical manifestation [
 <xref rid="B69-viruses-12-00211" ref-type="bibr">69</xref>]. Metagenomics reveals actual etiological factors, allowing for genotyping, identifying antibiotic resistance markers [
 <xref rid="B70-viruses-12-00211" ref-type="bibr">70</xref>] and supplying data molecular epidemiology [
 <xref rid="B71-viruses-12-00211" ref-type="bibr">71</xref>]. Recently, the applicability of HTS protocols to analyzing clinical samples has been evaluated, demonstrating high potential benefits for clinical studies [
 <xref rid="B58-viruses-12-00211" ref-type="bibr">58</xref>,
 <xref rid="B59-viruses-12-00211" ref-type="bibr">59</xref>,
 <xref rid="B72-viruses-12-00211" ref-type="bibr">72</xref>].
</p>
